Previous studies have also demonstrated that FGD5-AS1 activates the Wnt/β-catenin signaling pathway by regulating the miR-129-5p/HNRNPK axis, thus promoting the progression of glioblastoma [81]. Here, HNRNPK is linked to glioblastoma.